Daniel G. Mariam

Array ( [id] => 6514925 [patent_doc_number] => 20100216761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'NOVEL AZETIDINONES USEFUL AS INHIBITORS OF ELASTASE' [patent_app_type] => utility [patent_app_number] => 12/680289 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11864 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216761.pdf [firstpage_image] =>[orig_patent_app_number] => 12680289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6579828 [patent_doc_number] => 20100274003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'ACID ADDITION SALTS OF SYNTHETIC INTERMEDIATES FOR CARBAPENEM ANTIBIOTICS AND PROCESSES FOR PREPARING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/733674 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8615 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20100274003.pdf [firstpage_image] =>[orig_patent_app_number] => 12733674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178563 [patent_doc_number] => 20110178291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'Process for the manufacture of bridged monobactam intermediates' [patent_app_type] => utility [patent_app_number] => 12/676580 [patent_app_country] => US [patent_app_date] => 2008-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9224 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178291.pdf [firstpage_image] =>[orig_patent_app_number] => 12676580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8784740 [patent_doc_number] => 08431583 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-30 [patent_title] => 'Use of purine derivatives for the manufacture of a medicament' [patent_app_type] => utility [patent_app_number] => 12/675945 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4126 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12675945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272190 [patent_doc_number] => 20090075966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED TAZOBACTAM' [patent_app_type] => utility [patent_app_number] => 12/209031 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3047 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075966.pdf [firstpage_image] =>[orig_patent_app_number] => 12209031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272264 [patent_doc_number] => 20090076040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED VALGANCICLOVIR' [patent_app_type] => utility [patent_app_number] => 12/208773 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3316 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076040.pdf [firstpage_image] =>[orig_patent_app_number] => 12208773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272263 [patent_doc_number] => 20090076039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED VALACYCLOVIR' [patent_app_type] => utility [patent_app_number] => 12/206396 [patent_app_country] => US [patent_app_date] => 2008-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3384 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076039.pdf [firstpage_image] =>[orig_patent_app_number] => 12206396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272262 [patent_doc_number] => 20090076038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED ENTECAVIR' [patent_app_type] => utility [patent_app_number] => 12/206281 [patent_app_country] => US [patent_app_date] => 2008-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2915 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076038.pdf [firstpage_image] =>[orig_patent_app_number] => 12206281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272189 [patent_doc_number] => 20090075965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED AMOXICILIN' [patent_app_type] => utility [patent_app_number] => 12/205607 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3366 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075965.pdf [firstpage_image] =>[orig_patent_app_number] => 12205607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5453249 [patent_doc_number] => 20090069286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'DEUTERIUM-ENRICHED AZTREONAM' [patent_app_type] => utility [patent_app_number] => 12/203363 [patent_app_country] => US [patent_app_date] => 2008-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3178 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069286.pdf [firstpage_image] =>[orig_patent_app_number] => 12203363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441988 [patent_doc_number] => 20090093627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Process for preparing intermediates of ezetimibe by microbial reduction' [patent_app_type] => utility [patent_app_number] => 12/231438 [patent_app_country] => US [patent_app_date] => 2008-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2948 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093627.pdf [firstpage_image] =>[orig_patent_app_number] => 12231438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8114829 [patent_doc_number] => 08158635 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9H-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith' [patent_app_type] => utility [patent_app_number] => 12/200146 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 22804 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158635.pdf [firstpage_image] =>[orig_patent_app_number] => 12200146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5380338 [patent_doc_number] => 20090192177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => '2-ARYL pyrrologpyrimidines for A1 and A3 receptors' [patent_app_type] => utility [patent_app_number] => 12/231029 [patent_app_country] => US [patent_app_date] => 2008-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29178 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192177.pdf [firstpage_image] =>[orig_patent_app_number] => 12231029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4484581 [patent_doc_number] => 07902187 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => '6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression' [patent_app_type] => utility [patent_app_number] => 12/196516 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29613 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902187.pdf [firstpage_image] =>[orig_patent_app_number] => 12196516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509120 [patent_doc_number] => 20090082327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'DEUTERIUM-ENRICHED MEROPENEM' [patent_app_type] => utility [patent_app_number] => 12/196773 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3530 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082327.pdf [firstpage_image] =>[orig_patent_app_number] => 12196773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272191 [patent_doc_number] => 20090075967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED CEFTRIAXONE' [patent_app_type] => utility [patent_app_number] => 12/196762 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3347 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075967.pdf [firstpage_image] =>[orig_patent_app_number] => 12196762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272193 [patent_doc_number] => 20090075969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED DORIPENEM' [patent_app_type] => utility [patent_app_number] => 12/196920 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3149 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075969.pdf [firstpage_image] =>[orig_patent_app_number] => 12196920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4759977 [patent_doc_number] => 20080312203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Bicyclic 6-Alkylidene-Penems as Beta-Lactamase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/195706 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56942 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312203.pdf [firstpage_image] =>[orig_patent_app_number] => 12195706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4950137 [patent_doc_number] => 20080306263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Process For The Preparation Of Optically Pure Tetrahydropterins And Derivatives, And Specifically Of Optically Pure Tetrahydrofolic Acid And Derivatives Thereof, By Stereospecific Hydrogenation' [patent_app_type] => utility [patent_app_number] => 12/190945 [patent_app_country] => US [patent_app_date] => 2008-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14685 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306263.pdf [firstpage_image] =>[orig_patent_app_number] => 12190945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 142103 [patent_doc_number] => 07691842 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-06 [patent_title] => 'Tricyclic 6-alkylidene-penems as β-lactamase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/187707 [patent_app_country] => US [patent_app_date] => 2008-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77645 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/691/07691842.pdf [firstpage_image] =>[orig_patent_app_number] => 12187707 [rel_patent_id] =>[rel_patent_doc_number] =>)